Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 262

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Antifibrinolytic agents in current anaesthetic practice

Open access
Ortmann, E, Besser, M.W., Klein, A.A.·2013·British Journal of Anaesthesia

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bja/aet154

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Research works printed but not linked: 51

  1. Cardone, 2009, Perioperative blood conservation, Eur J Anaesthesiol, 26, 722, 10.1097/EJA.0b013e32832c5280 · doi:10.1097/eja.0b013e32832c5280
  2. Dietrich, 1996, Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?, J Cardiovasc Pharmacol, 27, S50, 10.1097/00005344-199600001-00011 · doi:10.1097/00005344-199600001-00011
  3. Westaby, 1993, Aprotinin in perspective, Ann Thorac Surg, 55, 1033, 10.1016/0003-4975(93)90149-C · doi:10.1016/0003-4975(93)90149-c
  4. Greilich, 2003, Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin, J Thorac Cardiovasc Surg, 126, 1498, 10.1016/S0022-5223(03)00946-2 · doi:10.1016/s0022-5223(03)00946-2
  5. Dorman, 2008, Differential effects of epsilon-aminocaproic acid and aprotinin on matrix metalloproteinase release in patients following cardiopulmonary bypass, J Cardiovasc Pharmacol, 51, 418, 10.1097/FJC.0b013e318168400a · doi:10.1097/fjc.0b013e318168400a
  6. Greilich, 2001, Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid, Circulation, 104, I265, 10.1161/hc37t1.094781 · doi:10.1161/hc37t1.094781
  7. Brown, 2009, Anti-inflammatory effect of aprotinin: a meta-analysis, J Extra Corpor Technol, 41, 79, 10.1051/ject/200941079 · doi:10.1051/ject/200941079
  8. Dietrich, 2007, Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery, Ann Thorac Surg, 84, 1144, 10.1016/j.athoracsur.2007.05.015 · doi:10.1016/j.athoracsur.2007.05.015
  9. Horrow, 1991, Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery, Circulation, 84, 2063, 10.1161/01.CIR.84.5.2063 · doi:10.1161/01.cir.84.5.2063
  10. Shore-Lesserson, 1996, Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery, Anesth Analg, 83, 18, 10.1213/00000539-199607000-00005 · doi:10.1213/00000539-199607000-00005
  11. Karski, 1995, Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial, J Thorac Cardiovasc Surg, 110, 835, 10.1016/S0022-5223(95)70118-4 · doi:10.1016/s0022-5223(95)70118-4
  12. Butterworth, 1999, Pharmacokinetics of epsilon-aminocaproic acid in patients undergoing aortocoronary bypass surgery, Anesthesiology, 90, 1624, 10.1097/00000542-199906000-00019 · doi:10.1097/00000542-199906000-00019
  13. Mohseni, 2009, Polymyoclonus seizure resulting from accidental injection of tranexamic acid in spinal anesthesia, Anesth Analg, 108, 1984, 10.1213/ane.0b013e3181a04d69 · doi:10.1213/ane.0b013e3181a04d69
  14. Garcha, 2007, Death after an inadvertent intrathecal injection of tranexamic acid, Anesth Analg, 104, 241, 10.1213/01.ane.0000250436.17786.72 · doi:10.1213/01.ane.0000250436.17786.72
  15. Yeh, 2003, Convulsions and refractory ventricular fibrillation after intrathecal injection of a massive dose of tranexamic acid, Anesthesiology, 98, 270, 10.1097/00000542-200301000-00042 · doi:10.1097/00000542-200301000-00042
  16. Martin, 2011, Seizures after open heart surgery: comparison of epsilon-aminocaproic acid and tranexamic acid, J Cardiothorac Anesth, 25, 20, 10.1053/j.jvca.2010.10.007 · doi:10.1053/j.jvca.2010.10.007
  17. Keyl, 2011, High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement, Eur J Cardiothorac Surg, 39, e114, 10.1016/j.ejcts.2010.12.030 · doi:10.1016/j.ejcts.2010.12.030
  18. Umlas, 1976, Fibrinolysis and disseminated intravascular coagulation in open heart surgery, Transfusion, 16, 460, 10.1046/j.1537-2995.1976.16577039303.x · doi:10.1046/j.1537-2995.1976.16577039303.x
  19. Tanaka, 1989, Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery, J Cardiothorac Anesth, 3, 181, 10.1016/S0888-6296(89)92642-2 · doi:10.1016/s0888-6296(89)92642-2
  20. Ngaage, 2010, Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies, Eur J Cardiothorac Surg, 37, 1375, 10.1016/j.ejcts.2009.11.055 · doi:10.1016/j.ejcts.2009.11.055
  21. Karkouti, 2010, The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery, Anesth Analg, 110, 21, 10.1213/ANE.0b013e3181c0ea6d · doi:10.1213/ane.0b013e3181c0ea6d
  22. Sander, 2010, Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis, Crit Care, 14, R148, 10.1186/cc9216 · doi:10.1186/cc9216
  23. Pasquali, 2012, Comparative analysis of antifibrinolytic medications in pediatric heart surgery, J Thorac Cardiovasc Surg, 143, 550, 10.1016/j.jtcvs.2011.06.048 · doi:10.1016/j.jtcvs.2011.06.048
  24. Shimizu, 2011, Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial, J Anesth, 25, 823, 10.1007/s00540-011-1235-z · doi:10.1007/s00540-011-1235-z
  25. Martin, 2011, Tranexamic acid versus varepsilon-aminocaproic acid: efficacy and safety in paediatric cardiac surgery, Eur J Cardiothorac Surg, 39, 892, 10.1016/j.ejcts.2010.09.041 · doi:10.1016/j.ejcts.2010.09.041
  26. Martin, 2011, Switch from aprotinin to epsilon-aminocaproic acid: impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery, Br J Anaesth, 107, 934, 10.1093/bja/aer267 · doi:10.1093/bja/aer267
  27. Martin, 2013, Replacement of aprotinin by {varepsilon}-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome, Br J Anaesth, 110, 615, 10.1093/bja/aes430 · doi:10.1093/bja/aes430
  28. Kon, 2006, Off-pump coronary artery bypass leads to a regional hypercoagulable state not detectable using systemic markers, Innovations (Phila), 1, 232, 10.1097/01.imi.0000242160.21278.b7 · doi:10.1097/01.imi.0000242160.21278.b7
  29. Raja, 2011, Hypercoagulable state after off-pump coronary artery bypass grafting: evidence, mechanisms and implications, Expert Rev Cardiovasc Ther, 9, 599, 10.1586/erc.11.51 · doi:10.1586/erc.11.51
  30. Desai, 2009, A randomized clinical trial investigating the relationship between aprotinin and hypercoagulability in off-pump coronary surgery, Anesth Analg, 109, 1387, 10.1213/ANE.0b013e3181b81068 · doi:10.1213/ane.0b013e3181b81068
  31. Weber, 2011, Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy, Eur J Anaesthesiol, 28, 57, 10.1097/EJA.0b013e32834050ab · doi:10.1097/eja.0b013e32834050ab
  32. Tauber, 2011, Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the ‘Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study’, Br J Anaesth, 107, 378, 10.1093/bja/aer158 · doi:10.1093/bja/aer158
  33. Wong, 2008, Tranexamic acid reduces perioperative blood loss in adult patients having spinal fusion surgery, Anesth Analg, 107, 1479, 10.1213/ane.0b013e3181831e44 · doi:10.1213/ane.0b013e3181831e44
  34. Dhawale, 2012, Are antifibrinolytics helpful in decreasing blood loss and transfusions during spinal fusion surgery in children with cerebral palsy scoliosis?, Spine, 37, E549, 10.1097/BRS.0b013e31823d009b · doi:10.1097/brs.0b013e31823d009b
  35. Verma, 2010, A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery, BMC Surg, 10, 13, 10.1186/1471-2482-10-13 · doi:10.1186/1471-2482-10-13
  36. Roullet, 2010, Rotation thromboelastometry detects thrombocytopenia and hypofibrinogenaemia during orthotopic liver transplantation, Br J Anaesth, 104, 422, 10.1093/bja/aeq022 · doi:10.1093/bja/aeq022
  37. Porte, 2000, Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group, Lancet, 355, 1303, 10.1016/S0140-6736(00)02111-5 · doi:10.1016/s0140-6736(00)02111-5
  38. Dalmau, 2000, Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation, Anesth Analg, 91, 29
  39. Dalmau, 2004, The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study, Liver Transpl, 10, 279, 10.1002/lt.20075 · doi:10.1002/lt.20075
  40. Massicotte, 2011, Aprotinin versus tranexamic acid during liver transplantation: impact on blood product requirements and survival, Transplantation, 91, 1273, 10.1097/TP.0b013e31821ab9f8 · doi:10.1097/tp.0b013e31821ab9f8
  41. Ickx, 2006, Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation, Transfusion, 46, 595, 10.1111/j.1537-2995.2006.00770.x · doi:10.1111/j.1537-2995.2006.00770.x
  42. Warnaar, 2009, Aprotinin and the risk of thrombotic complications after liver transplantation: a retrospective analysis of 1492 patients, Liver Transpl, 15, 747, 10.1002/lt.21768 · doi:10.1002/lt.21768
  43. Trzebicki, 2010, The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products, Ann Transplant, 15, 19
  44. Gorlinger, 2006, Coagulation management during liver transplantation, Hamostaseologie, 26, S64, 10.1055/s-0037-1617084 · doi:10.1055/s-0037-1617084
  45. Gohel, 2007, Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomised case controlled prospective study, J Obstet Gynaecol India, 57, 227
  46. Rosenorn, 1987, The risk of rebleeding from ruptured intracranial aneurysms, J Neurosurg, 67, 329, 10.3171/jns.1987.67.3.0329 · doi:10.3171/jns.1987.67.3.0329
  47. Starke, 2011, Rebleeding after aneurysmal subarachnoid hemorrhage, Neurocritical Care, 15, 241, 10.1007/s12028-011-9581-0 · doi:10.1007/s12028-011-9581-0
  48. Roos, 2000, Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group, Neurology, 54, 77, 10.1212/WNL.54.1.77 · DOI
  49. Hillman, 2002, Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study, J Neurosurg, 97, 771, 10.3171/jns.2002.97.4.0771 · DOI
  50. Starke, 2008, Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage, Stroke, 39, 2617, 10.1161/STROKEAHA.107.506097 · doi:10.1161/strokeaha.107.506097
  51. Harrigan, 2010, Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus, Neurosurgery, 67, 935, 10.1227/NEU.0b013e3181ebaa36 · doi:10.1227/neu.0b013e3181ebaa36

Cited by

See all 262

Metadata

Authors
Ortmann, E., Besser, M. W., & Klein, A. A.
Venue
British Journal of Anaesthesia
Publisher
Elsevier BV
Published
2013-10
Volume
111
Issue
4
Pages
549-563
ISSN
0007-0912 (ISSN-L)
OpenAlex
W2132175922
Cited by
262
References
62
FWCI
14.68
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antifibrinolytic agents in current anaesthetic practice. https://app.cochat.ai/papers/10.1093/bja/aet154
The paper
Ortmann, E., Besser, M. W., & Klein, A. A. (2013). Antifibrinolytic agents in current anaesthetic practice. British Journal of Anaesthesia. https://doi.org/10.1093/bja/aet154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.